Imagen de Portada

Angiogenesis in Cancers

Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many rep...

Descripción completa

Guardado en:
Formato: Online
Lenguaje:inglés
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2023
Materias:
RBP4
metastasis
breast cancer
angiogenesis
endothelial dysfunction
STAT3
VEGF
endothelin-1
resveratrol
gemcitabine
endoglin
ERKs
microvessel growth
lung cancer
cancer
anticancer
DLBCL
tumor microenvironment
cell adhesion mediated drug resistance
tumor progression
VEGFR
anti-angiogenesis
anti-angiogenic agents
immunosuppression
immunotherapy
immune-checkpoint inhibitors
combination therapy
tumor angiogenesis
endothelium
microenvironment
multiple myeloma
adhesion molecules
immune-checkpoint inhibitor
tumor-derived exosomes
small extracellular vesicles
feline mammary carcinoma
VEGF-A
VEGFR-1
VEGFR-2
non-invasive biomarkers
selectins
E-selectin
uproleselan
adrenal fetal cortex
adrenocortical tumors
adrenocortical carcinoma
anti-angiogenic drugs
bFGF
anti-angiogenic therapy
resistance
vascular permeability
drug delivery system
microbeam radiation therapy (MRT)
Chicken Chorioallantoic Membrane (CAM)
U-87 Glioblastoma
ginsenoside Rg3
response surface methodology
optimisation
epimer
long pentraxin 3
FGF/FGFR system
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Acceso en línea:ONIX_20230405_9783036569161_238
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

ONIX_20230405_9783036569161_238

Ejemplares similares